Percutaneous coronary intervention for acute MI does not prevent in-hospital development of cardiogenic shock compared to fibrinolysis

European Journal of Heart Failure

Volumn 10, Issue 7, 2008, Pages 668-674

  Lindholm, Matias G ^a   Boesgaard, Søren ^a   Thune, Jens Jakob ^a   Kelbaek, Henning ^a   Andersen, Henning Rud ^b   Kober, Lars ^a  

^a Rigshospitalet   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute heart failure; Acute myocardial infarction; Angioplasty; Cardiogenic shock; Revascularization

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HOSPITAL PATIENT; HUMAN; HYPOTENSION; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RISK; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; ST SEGMENT ELEVATION; TACHYCARDIA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; DENMARK; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SHOCK, CARDIOGENIC; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 46149085122     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2008.04.015     Document Type: Article

References (30)

1. Faxon D.P. Early reperfusion strategies after acute ST-segment elevation myocardial infarction: the importance of timing. Nat Clin Pract Cardiovasc Med 2 1 (2005) 22-28
2. Svensson L., Aasa M., Dellborg M., et al. Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J 151 4 (2006) 798-7
3. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 9351 (2003) 13-20
4. Michels K.B., and Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 91 2 (1995) 476-485
5. Babaev A., Frederick P.D., Pasta D.J., Every N., Sichrovsky T., and Hochman J.S. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294 4 (2005) 448-454
6. Hochman J.S., Sleeper L.A., White H.D., et al. One-year survival following early revascularization for cardiogenic shock. JAMA 285 2 (2001) 190-192
7. Nieminen M.S., Bohm M., Cowie M.R., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 4 (2005) 384-416
8. Andersen H.R., Nielsen T.T., Vesterlund T., et al. Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2). Am Heart J 146 2 (2003) 234-241
9. Morrow D.A., Antman E.M., Charlesworth A., et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 102 17 (2000) 2031-2037
10. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 27 7 (2006) 779-788
11. Thune J.J., Hoefsten D.E., Lindholm M.G., et al. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation 112 13 (2005) 2017-2021
12. Bradley E.H., Herrin J., Wang Y., et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 355 22 (2006) 2308-2320
13. Goldberg R.J., Samad N.A., Yarzebski J., Gurwitz J., Bigelow C., and Gore J.M. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 340 15 (1999) 1162-1168
14. Lindholm M.G., Kober L., Boesgaard S., Torp-Pedersen C., and Aldershvile J. Cardiogenic Shock Complicating Acute MI: significance of time to development of Shock. Eur Heart J (2003)
15. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med 336 23 (1997) 1621-1628
16. Bonnefoy E., Lapostolle F., Leizorovicz A., et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 360 9336 (2002) 825-829
17. Berrocal D.H., Cohen M.G., Spinetta A.D., et al. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase. Am Heart J 146 6 (2003) E22
18. Levitsky S. Protecting the myocardial cell during coronary revascularization. The William W. L. Glenn Lecture. Circulation 114 1 Suppl (2006) I339-I343
19. Rodriguez-Sinovas A., Abdallah Y., Piper H.M., and Garcia-Dorado D. Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction. Heart Fail Rev 12 3-4 (2007) 207-216
20. Montalescot G., Barragan P., Wittenberg O., et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 344 25 (2001) 1895-1903
21. Stone G.W., Grines C.L., Cox D.A., et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 346 13 (2002) 957-966
22. Kastrati A., Mehilli J., Dirschinger J., et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet 359 9310 (2002) 920-925
23. Antoniucci D., Valenti R., Migliorini A., et al. Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation. Am J Cardiol 90 4 (2002) 353-357
24. Holmes D.R.J., Bates E.R., Kleiman N.S., et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 26 3 (1995) 668-674
25. Becker R.C., Gore J.M., Lambrew C., et al. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol 27 6 (1996) 1321-1326
26. de Boer M.J., Hoorntje J.C., Ottervanger J.P., Reiffers S., Suryapranata H., and Zijlstra F. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol 23 5 (1994) 1004-1008
27. Sleeper L.A., Ramanathan K., Picard M.H., et al. Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 46 2 (2005) 266-273
28. Kohsaka S., Menon V., Lowe A.M., et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 165 14 (2005) 1643-1650
29. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107 24 (2003) 2998-3002
30. Menon V., Slater J.N., White H.D., Sleeper L.A., Cocke T., and Hochman J.S. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med 108 5 (2000) 374-380